<DOC>
	<DOCNO>NCT01577563</DOCNO>
	<brief_summary>RATIONAL multinational , multicentre , observational , cross sectional study adult patient treatment NSAID therapy OA , RA AS least 2 week study visit ( least one dose ) .</brief_summary>
	<brief_title>Prevalence Study Gastrointestinal Risk Factors Patients With Osteoarthritis ( OA ) , Rheumatoid Arthritis ( RA ) Ankylosing Spondylitis ( AS ) .</brief_title>
	<detailed_description>Prevalence study gastrointestinal risk factor patient osteoarthritis , rheumatoid arthritis ankylose spondylitis receive treatment non- steroidal anti- inflammatory drug .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<mesh_term>Anti-Inflammatory Agents , Non-Steroidal</mesh_term>
	<criteria>Provision subject inform consent . Female and/or male , age &gt; 21 year . Patients diagnosis RA ( ACR 1987 ACR/EULAR 2010 criterion ) , OA ( ACR 1986 , 1990 1991 criterion ) AS ( New York 1984 criterion ESSG 2002 criterion ) ( document medical record ) . Patients receive least one dose NSAIDs . Participation interventional study involve investigational drug . Patient refuse fill study questionnaire . Pregnant breastfeed woman . Patients active neoplastic disease last 5 year , except basalcell carcinoma .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>osteoarthritis ( OA )</keyword>
	<keyword>rheumatoid arthritis ( RA )</keyword>
	<keyword>ankylose spondylitis ( AS )</keyword>
	<keyword>gastrointestinal risk factor</keyword>
	<keyword>NSAIDs</keyword>
</DOC>